Product Reports Resources Pricing Login Book a demo
Power Law company profile

Niagen Bioscience

Biotech & Life Sciences · Los Angeles, United States · Founded 1999 Colt

An integrated global nutraceutical company devoted to improving the way people age

Valuation
$558M
Market cap · 2026
Revenue
$100M
Latest reported FY
EBITDA
$9.2M
Latest reported FY

Global footprint

Where Niagen Bioscience has talent and traffic

Workforce by country
🇺🇸 United States · Los Angeles HQ
Book a demo for the full country breakdown
Web traffic by country
11K monthly visits
across markets
🇺🇸 United States128.2%
🇬🇧 United Kingdom15.5%
🇮🇳 India11.8%
🇫🇷 France3.6%
🇨🇦 Canada2.7%
Top 5 markets shown

Market sentiment

What the market is saying about Niagen Bioscience

An AI-synthesized read of the highest-engagement posts about Niagen Bioscience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Niagen Bioscience on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.